Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U et al (2019) 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J 40(2):87–165. https://doi.org/10.1093/eurheartj/ehy394

Article  PubMed  Google Scholar 

Qian F, Zhong Y, Hannan EL (2020) Relation between operator and hospital volumes and long-term outcomes for percutaneous coronary intervention in New York. Am J Cardiol 125(5):694–711. https://doi.org/10.1016/j.amjcard.2019.11.034

Article  PubMed  Google Scholar 

Werner N, Nickenig G, Sinning JM (2018) Complex PCI procedures: challenges for the interventional cardiologist. Clin Res Cardiol 107(Suppl 2):64–73. https://doi.org/10.1007/s00392-018-1316-1

Article  PubMed  Google Scholar 

Lawton JS, Tamis-Holland JE, Bangalore S, Bates ER, Beckie TM, Bischoff JM et al (2022) 2021 ACC/AHA/SCAI guideline for coronary artery revascularization: executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 145(3):e4–e17. https://doi.org/10.1161/CIR.0000000000001039

Article  PubMed  Google Scholar 

McFadden EP, Stabile E, Regar E, Cheneau E, Ong AT, Kinnaird T et al (2004) Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 364(9444):1519–1521. https://doi.org/10.1016/S0140-6736(04)17275-9

Article  CAS  PubMed  Google Scholar 

Armstrong EJ, Sab S, Singh GD, Lim W, Yeo KK, Waldo SW et al (2014) Predictors and outcomes of recurrent stent thrombosis: results from a multicenter registry. JACC Cardiovasc Interv 7(10):1105–1113. https://doi.org/10.1016/j.jcin.2014.05.017

Article  PubMed  Google Scholar 

Capodanno D, Alfonso F, Levine GN, Valgimigli M, Angiolillo DJ. ACC/AHA versus esc guidelines on dual antiplatelet therapy: JACC guideline comparison. J Am Coll Cardiol. 2018;72(23 Pt A):2915–31. https://doi.org/10.1016/j.jacc.2018.09.057.

Piccolo R, Giustino G, Mehran R, Windecker S (2015) Stable coronary artery disease: revascularisation and invasive strategies. Lancet 386(9994):702–713. https://doi.org/10.1016/S0140-6736(15)61220-X

Article  PubMed  Google Scholar 

Mehran R, Giustino G, Baber U (2015) DAPT duration after DES: what is the “mandatory” duration? J Am Coll Cardiol 65(11):1103–1106. https://doi.org/10.1016/j.jacc.2015.01.024

Article  PubMed  Google Scholar 

Colombo A, Chieffo A, Frasheri A, Garbo R, Masotti-Centol M, Salvatella N et al (2014) Second-generation drug-eluting stent implantation followed by 6- versus 12-month dual antiplatelet therapy: the SECURITY randomized clinical trial. J Am Coll Cardiol 64(20):2086–2097. https://doi.org/10.1016/j.jacc.2014.09.008

Article  CAS  PubMed  Google Scholar 

Mauri L, Kereiakes DJ, Yeh RW, Driscoll-Shempp P, Cutlip DE, Steg PG et al (2014) Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents. N Engl J Med 371(23):2155–2166. https://doi.org/10.1056/NEJMoa1409312

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yamamoto K, Shiomi H, Morimoto T, Takeji Y, Yoshikawa Y, Natsuaki M et al (2021) Ischemic and bleeding risk after complex percutaneous coronary intervention in patients with or without high bleeding risk. Catheter Cardiovasc Interv 97(6):E758–E770. https://doi.org/10.1002/ccd.29335

Article  PubMed  Google Scholar 

Ueki Y, Karagiannis A, Zanchin C, Zanchin T, Stortecky S, Koskinas KC et al (2019) Validation of high-risk features for stent-related ischemic events as endorsed by the 2017 DAPT guidelines. JACC Cardiovasc Interv 12(9):820–830. https://doi.org/10.1016/j.jcin.2018.12.005

Article  PubMed  Google Scholar 

Vrints C, Andreotti F, Koskinas KC, Rossello X, Adamo M, Ainslie J et al (2024) ESC guidelines for the management of chronic coronary syndromes. Eur Heart J 45(36):3415–3537. https://doi.org/10.1093/eurheartj/ehae177

Zeymer U, Cully M, Hochadel M (2018) Adherence to dual antiplatelet therapy with ticagrelor in patients with acute coronary syndromes treated with percutaneous coronary intervention in real life. Results of the REAL-TICA registry. Eur Heart J Cardiovasc Pharmacother 4(4):205–10. https://doi.org/10.1093/ehjcvp/pvy018.

Yamamoto K, Watanabe H, Morimoto T, Domei T, Ohya M, Ogita M et al (2021) Very short dual antiplatelet therapy after drug-eluting stent implantation in patients who underwent complex percutaneous coronary intervention: insight from the STOPDAPT-2 trial. Circ Cardiovasc Interv 14(5):e010384. https://doi.org/10.1161/CIRCINTERVENTIONS.120.010384

Article  PubMed  Google Scholar 

Valgimigli M, Bueno H, Byrne RA, Collet JP, Costa F, Jeppsson A et al (2018) 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS. Eur J Cardiothorac Surg 53(1):34–78. https://doi.org/10.1093/ejcts/ezx334

Article  PubMed  Google Scholar 

Giustino G, Chieffo A, Palmerini T, Valgimigli M, Feres F, Abizaid A et al (2016) Efficacy and safety of dual antiplatelet therapy after complex PCI. J Am Coll Cardiol 68(17):1851–1864. https://doi.org/10.1016/j.jacc.2016.07.760

Article  CAS  PubMed  Google Scholar 

Higgins JPT, Green S, Cochrane C (2022) Cochrane handbook for systematic reviews of interventions. Cochrane Collaboration, Oxford

Google Scholar 

Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https://doi.org/10.1136/bmj.n71

Article  PubMed  PubMed Central  Google Scholar 

Garcia-Garcia HM, McFadden EP, Farb A, Mehran R, Stone GW, Spertus J et al (2018) Standardized end point definitions for coronary intervention trials: the academic research consortium-2 consensus document. circulation 137(24):2635–50. https://doi.org/10.1161/CIRCULATIONAHA.117.029289.

Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD et al (2011) The Cochrane collaboration’s tool for assessing risk of bias in randomised trials. BMJ 343:d5928. https://doi.org/10.1136/bmj.d5928

Article  PubMed  PubMed Central  Google Scholar 

Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109):629–634. https://doi.org/10.1136/bmj.315.7109.629

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dangas G, Baber U, Sharma S, Giustino G, Mehta S, Cohen DJ et al (2020) Ticagrelor with or without aspirin after complex PCI. J Am Coll Cardiol 75(19):2414–2424. https://doi.org/10.1016/j.jacc.2020.03.011

Article  CAS  PubMed  Google Scholar 

Roh JW, Hahn JY, Oh JH, Chun WJ, Park YH, Jang WJ et al (2021) P2Y12 inhibitor monotherapy in complex percutaneous coronary intervention: a post-hoc analysis of SMART-CHOICE randomized clinical trial. Cardiol J 28(6):855–863. https://doi.org/10.5603/CJ.a2021.0101

Article  PubMed  PubMed Central  Google Scholar 

Serruys PW, Takahashi K, Chichareon P, Kogame N, Tomaniak M, Modolo R et al (2019) Impact of long-term ticagrelor monotherapy following 1-month dual antiplatelet therapy in patients who underwent complex percutaneous coronary intervention: insights from the Global Leaders trial. Eur Heart J 40(31):2595–2604. https://doi.org/10.1093/eurheartj/ehz453

Article  CAS  PubMed  Google Scholar 

Valgimigli M, Smits PC, Frigoli E, Bongiovanni D, Tijssen J, Hovasse T et al (2022) Duration of antiplatelet therapy after complex percutaneous coronary intervention in patients at high bleeding risk: a MASTER DAPT trial sub-analysis. Eur Heart J 43(33):3100–3114. https://doi.org/10.1093/eurheartj/ehac284

Article  PubMed  Google Scholar 

Yeh RW, Kereiakes DJ, Steg PG, Cutlip DE, Croce KJ, Massaro JM et al (2017) Lesion complexity and outcomes of extended dual antiplatelet therapy after percutaneous coronary intervention. J Am Coll Cardiol 70(18):2213–2223. https://doi.org/10.1016/j.jacc.2017.09.011

Article  PubMed  PubMed Central  Google Scholar 

Han JK, Lee K, Park SH, Yang S, Hwang D, Kang J et al (2025) Short-term DAPT after complex PCI with third-generation DES: a post hoc analysis of the HOST-IDEA trial. Circ Cardiovasc Interv 18(5):e014623. https://doi.org/10.1161/CIRCINTERVENTIONS.124.014623

Article  CAS  PubMed  Google Scholar 

Byrne RA, Rossello X, Coughlan JJ, Barbato E, Berry C, Chieffo A et al (2023) ESC Guidelines for the management of acute coronary syndromes. Eur Heart J 44(38):3720–3826. https://doi.org/10.1093/eurheartj/ehad191

Dangas GD, Claessen BE, Mehran R, Xu K, Fahy M, Parise H et al (2012) Development and validation of a stent thrombosis risk score in patients with acute coronary syndromes. JACC Cardiovasc Interv 5(11):1097–1105. https://doi.org/10.1016/j.jcin.2012.07.012

Article  PubMed  Google Scholar 

Costa F, Van Klaveren D, Feres F, James S, Raber L, Pilgrim T et al (2019) Dual antiplatelet therapy duration based on ischemic and bleeding risks after coronary stenting. J Am Coll Cardiol 73(7):741–754. https://doi.org/10.1016/j.jacc.2018.11.048

Article  PubMed  Google Scholar 

Leone A, Simonetti F, Avvedimento M, Angellotti D, Immobile Molaro M, Franzone A et al (2022) Ultrathin struts drug-eluting stents: a state-of-the-art review. J Pers Med 12(9). https://doi.org/10.3390/jpm12091378.